Effectiveness of pharmacological smoking cessation treatments: a retrospective comparison of common methods

Objective: This study aimed to compare the short-term (three-month) effectiveness of three smoking cessation therapies, bupropion, nicotine patch, and cytisine, and to retrospectively evaluate the impact of cytisine therapy on craving reduction and its side effect profile under routine clinical practice conditions. Methods: A total of 565 individuals who presented to the Smoking Cessation Outpatient Clinic between February 2024 and January 2025 and completed treatment with either cytisine, bupropion, or nicotine patch were included in the study. Demographic characteristics, chronic disease status, Fagerström Test for Nicotine Dependence (FTND) scores, and smoking cessation outcomes were assessed to compare treatment success across the three therapies. Among patients treated with cytisine, early craving reduction and reported side effects during the first week were recorded and analyzed in relation to cessation outcomes. Statistical significance was set at p

Authors

Institutions

Publication Details

Journal
Turkish Journal of Family Practice
Published
2025-09-30
DOI
https://doi.org/10.54308/turkjfampract.2025.877
Primary Topic
Smoking Behavior and Cessation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness of pharmacological smoking cessation treatments: a retrospective comparison of common methods

Yağmur Gökseven, Güzin Zeren Öztürk, Ebru Kocatürk Güllü
Turkish Journal of Family Practice
Smoking Behavior and Cessation
article

Effectiveness of pharmacological smoking cessation treatments: a retrospective comparison of common methods

Yağmur Gökseven, Güzin Zeren Öztürk, Ebru Kocatürk Güllü
article en

Abstract

Objective: This study aimed to compare the short-term (three-month) effectiveness of three smoking cessation therapies, bupropion, nicotine patch, and cytisine, and to retrospectively evaluate the impact of cytisine therapy on craving reduction and its side effect profile under routine clinical practice conditions. Methods: A total of 565 individuals who presented to the Smoking Cessation Outpatient Clinic between February 2024 and January 2025 and completed treatment with either cytisine, bupropion, or nicotine patch were included in the study. Demographic characteristics, chronic disease status, Fagerström Test for Nicotine Dependence (FTND) scores, and smoking cessation outcomes were assessed to compare treatment success across the three therapies. Among patients treated with cytisine, early craving reduction and reported side effects during the first week were recorded and analyzed in relation to cessation outcomes. Statistical significance was set at p

Turkish Journal of Family PracticeVol. 29(3)
Sağlık Bilimleri Üniversitesi (TR), Ford Otosan (Turkey) (TR), AVL (Turkey) (TR), Şişli Etfal Eğitim ve Araştırma Hastanesi (TR), University of Health Sciences Antigua (AG)
Openalex Percentile: Top 66%
Smoking Behavior and Cessation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.